血浆纤维蛋白原与前列腺癌骨转移的相关性及诊断价值研究

doi:10.3877/cma.j.issn.1674-3253.2021.02.011

目的

研究血浆纤维蛋白原（Fib）与前列腺癌骨转移的相关性及诊断价值。

方法

回顾性分析2016年1月至2019年12月于张家港市第五人民医院泌尿外科住院治疗的148例前列腺癌患者的临床资料，根据是否存在骨转移分为骨转移组40例和非骨转移组108例。分别记录两组患者血浆Fib、前列腺特异性抗原（PSA）、Gleason评分及肿瘤分期等指标的差异。采用多因素Logistic回归分析检验前列腺癌骨转移危险因素。根据全身核素骨扫描检查结果将骨转移组患者按照病灶数目分为单发骨转移组（18例）和多发骨转移组（22例），比较两组间血浆Fib及PSA水平的差异。应用受试者工作特征（ROC）曲线分析血浆Fib对前列腺癌骨转移的辅助诊断价值。

结果

骨转移组血浆Fib及PSA水平明显高于非骨转移组，且骨转移组Gleason评分>7分及肿瘤分期T3-4患者比例明显高于非骨转移组（P<0.05）。多因素Logistic回归分析的结果显示Fib升高、Gleason评分>7及肿瘤分期T3-4均是前列腺癌骨转移的独立危险因素。多发骨转移组血浆Fib水平均明显高于单发骨转移组（P<0.05），但两组间血浆PSA水平比较差异无统计学意义（P>0.05）。血浆Fib诊断前列腺癌骨转移的ROC曲线下面积AUC）为0.742（95% CI：0.645～0.841）。当血浆Fib诊断临界值取3.61 g/L时，其诊断效能最高，敏感度为68.6％，特异度为76.2％。

结论

血浆Fib水平与前列腺癌骨转移程度呈正相关，并对诊断前列腺癌骨转移具有一定的诊断价值。

关键词: 血浆纤维蛋白原, 前列腺肿瘤, 骨转移, 诊断价值, 相关性

Objective

To explore the correlation and diagnostic value of plasma fibrinogen (Fib) with bone metastasis in prostate cancer patients.

Methods

The clinical data of 148 patients with prostate cancer in the Fifth People's Hospital of Zhangjiagang City from January 2016 to December 2019 were retrospectively analyzed. They were divided into bone metastasis group (n=40) and non-bone metastasis group (n=108). The differences of plasma Fib, prostate specific antigen (PSA), Gleason score and tumor stage were recorded in the two groups. Multi-factor Logistic regression analysis was used to analysis the risk factors of prostate cancer bone metastasis. According to the results of systemic radionuclide bone scan, patients in the bone metastasis group were divided into single bone metastasis group (18 cases) and multiple bone metastasis group (22 cases) according to the number of lesions. The differences in plasma Fib and PSA levels between the two groups were compared. The receiver operating characteristic (ROC) curve was used to analyze the diagnostic value of plasma Fib in prostate cancer bone metastasis.

Results

The plasma Fib and PSA levels in the bone metastasis group were significantly higher than those in the non-bone metastasis group, and the Gleason score >7 and tumor stage T3-4 patients in the bone metastasis group were significantly more than the non-bone metastasis group (P<0.05). The results of multivariate logistic regression analysis showed that increased Fib, Gleason score >7, and tumor stage T3-4 were all independent risk factors for bone metastasis of prostate cancer.The plasma Fib level in the multiple bone metastasis group was significantly higher than that in the single bone metastasis group (P<0.05), but there was no statistically significant difference in plasma PSA levels between the two groups (P>0.05). The area under the ROC curve (AUC) of plasma Fib used to diagnose bone metastases in prostate cancer was 0.742 (95% CI:0.645 to 0.841). When the diagnostic critical value of plasma Fib is 3.61 g/L, its diagnostic efficiency is the highest, with a sensitivity of 68.6% and a specificity of 76.2%.

Conclusion

he plasma Fib level is positively correlated with the degree of prostate cancer bone metastasis, and has certain diagnostic value for the diagnosis of prostate cancer bone metastasis.

Key words: Plasma fibrinogen, Prostate cancer, Bone metastasis, Diagnostic value, Correlation

表1 两组前列腺癌患者基本资料比较

组别	例数	年龄[岁，(±s)]	高血压(例)	糖尿病(例)	吸烟(例)	饮酒(例)	家族史(例)	肌酐[μmol/L，(±s)]
非骨转移组	108	66±8	16	20	25	29	10	70±14
骨转移组	40	70±9	6	4	8	10	5	74±15
统计值		t=1.514	χ²=0.160	χ²=1.559	χ²=0.167	χ²=0.052	χ²=0.075	t=0.928
组别	WBC[×10⁹/L，(±s)]	N[×10⁹/L，(±s)]	Fib[g/L，(±s)]	PSA[ng/ml，(±s)]	Gleason评分(≤7/>7)	肿瘤分期(T1-2/T3-4)
非骨转移组	7.47±1.19	4.49±1.11	2.50±0.49	30±10	78/30	59/49
骨转移组	8.02±1.37	5.08±0.84	3.89±0.59	82±20	22/18	11/29
统计值	t=1.117	t=1.298	t=4.125^*	t=10.268^*	χ²=3.951^*	χ²=8.619^*

表1 两组前列腺癌患者基本资料比较

组别	例数	年龄[岁，(±s)]	高血压(例)	糖尿病(例)	吸烟(例)	饮酒(例)	家族史(例)	肌酐[μmol/L，(±s)]
非骨转移组	108	66±8	16	20	25	29	10	70±14
骨转移组	40	70±9	6	4	8	10	5	74±15
统计值		t=1.514	χ²=0.160	χ²=1.559	χ²=0.167	χ²=0.052	χ²=0.075	t=0.928
组别	WBC[×10⁹/L，(±s)]	N[×10⁹/L，(±s)]	Fib[g/L，(±s)]	PSA[ng/ml，(±s)]	Gleason评分(≤7/>7)	肿瘤分期(T1-2/T3-4)
非骨转移组	7.47±1.19	4.49±1.11	2.50±0.49	30±10	78/30	59/49
骨转移组	8.02±1.37	5.08±0.84	3.89±0.59	82±20	22/18	11/29
统计值	t=1.117	t=1.298	t=4.125^*	t=10.268^*	χ²=3.951^*	χ²=8.619^*

表2 影响前列腺癌骨转移的多因素Logistic回归分析

变量	B	SE	Wald χ²	P值	OR（95% CI）
Fib	1.128	0.336	11.270	<0.001	3.987(2.025～10.998)
PSA	0.625	0.442	1.999	0.128	1.209(0.658～3.220)
Gleason评分>7	0.889	0.267	11.089	<0.001	1.558(1.197～2.698)
肿瘤分期T3-4	1.005	0.355	8.015	0.003	2.112(1.069～4.187)

表2 影响前列腺癌骨转移的多因素Logistic回归分析

变量	B	SE	Wald χ²	P值	OR（95% CI）
Fib	1.128	0.336	11.270	<0.001	3.987(2.025～10.998)
PSA	0.625	0.442	1.999	0.128	1.209(0.658～3.220)
Gleason评分>7	0.889	0.267	11.089	<0.001	1.558(1.197～2.698)
肿瘤分期T3-4	1.005	0.355	8.015	0.003	2.112(1.069～4.187)

表3 不同组别患者血浆Fib及PSA水平的比较

组别	例数	Fib（g/L）	PSA（ng/mL）
单发骨转移组	18	3.17±0.61	79.22±11.35
多发骨转移组	22	3.92±0.56	85.66±19.38
t值		5.968^*	1.587

表3 不同组别患者血浆Fib及PSA水平的比较

组别	例数	Fib（g/L）	PSA（ng/mL）
单发骨转移组	18	3.17±0.61	79.22±11.35
多发骨转移组	22	3.92±0.56	85.66±19.38
t值		5.968^*	1.587

图1 血浆Fib诊断前列腺癌骨转移的ROC曲线

[1]	Xu Z, Ma T, Zhou J, et al. Nuclear receptor ERRα contributes to castration-resistant growth of prostate cancer via its regulation of intratumoral androgen biosynthesis[J].Theranostics, 2020, 10(9): 4201-4216.
[2]	Baptista S, Heleno B, Pinto M,et al.Translation and cultural adaptation of a prostate cancer screening decision aid: a qualitative study in Portugal[J]. BMJ open, 2020, 10(3): e034384.
[3]	李淼沅，袁润强，陈业辉. 前列腺癌并骨转移的治疗新进展[J/CD]. 中华腔镜泌尿外科杂志(电子版). 2018, 12(2): 73-75.
[4]	Wang Y, Singhal U, Qiao Y, et al. Wnt signaling drives prostate cancer bone metastatic tropism and invasion[J]. Transl oncol, 2020, 13(4): 100747.
[5]	John AE.Platelets and fibrinogen: emerging complexity in trauma-induced coagulopathy[J]. Semin Thromb Hemost, 2020, 46(2): 125-133.
[6]	Maconachie S, Jansen M, Cottle E,et al. Viscoelastic haemostatic assays and fibrinogen in paediatric acute traumatic coagulopathy: A comprehensive review[J].Emerg Med Australas, 2020, 32(2): 313-319.
[7]	Dai T, Peng L, Lin G,et al.Preoperative elevated plasma fibrinogen level predicts tumor recurrence and poor prognosis in patients with hepatocellular carcinoma[J].J Gastrointest Oncol, 2019, 10(6): 1049-1063.
[8]	Chen B, Cao DH, Guo JB, et al. Androgen biosynthesis in castration-resistant prostate cancer: Advances in studies][J]. Zhonghua nan ke xue, 2019, 25(3): 265-271.
[9]	中华医学会泌尿外科学分会前列腺癌联盟. 中国前列腺癌早期诊断专家共识[J]. 中华泌尿外科杂志, 2015, 36(8) :561-564.
[10]	Khorasani M, Shahbazi S, Hosseinkhan N. Analysis of differential expression of micrornas and their target genes in prostate cancer: a bioinformatics study on microarray gene expression data[J]. Int J Mol and Cell Med, 2019, 8(2): 103-114.
[11]	Wu FJ, Li IH, Chien WC, et al. Androgen deprivation therapy and the risk of iron-deficiency anaemia among patients with prostate cancer: a population-based cohort study[J]. BMJ open, 2020, 10(3): e034202.
[12]	Askari M, Yazdani A, Yazdani M.Serum levels of total and urine level of PCA3 in patients with benign prostatic hyperplasia and prostate cancer[J]. Ame J clin Exp Urol, 2020, 8(1): 43-47.
[13]	Alwanian WM. Protein tyrosine kinase 6 signaling in prostate cancer[J]. Ame J clin Exp Urol, 2020, 8(1): 1-8.
[14]	Liu W, Li W, Wang Z, et al. Metabolically abnormal obesity increases the risk of advanced prostate cancer in chinese patients undergoing radical prostatectomy[J]. Cancer Manag Res, 2020, 12(1): 1779-1787.
[15]	Tran C, Dicker A, Leiby B, et al. Utilizing digital health to collect electronic patient-reported outcomes in prostate cancer: single-arm pilot trial[J]. J Med Int Res, 2020, 22(3): e12689.
[16]	Sorra E, Aziz MU. Isolated hepatic metastasis of prostate cancer with variable f-fluociclovine uptake by pet/ct imaging[J]. Nucl Med Mol Imaging, 2020, 54(1): 53-57.
[17]	Deek MP. Oligometastatic and oligoprogression disease and local therapies in prostate cancer[J].Cancer J, 2020, 26(2): 137-143.
[18]	Song J, Yu T, Sun Z, et al. Comparison of prognostic significance between serum fibrinogen and global registry of acute coronary events score for prognosis of patients with non-st-elevation acute coronary syndromes undergoing percutaneous coronary intervention[J]. Coron Artery Dis, 2020, 31(2): 124-129.
[19]	Sorra E, Aziz MU. Isolated hepatic metastasis of prostate cancer with variable f-fluociclovine uptake by pet/ct imaging[J]. Nucl Med Mol Imaging, 2020, 54(1): 53-57.

[1]	周荷妹, 金杰, 叶建东, 夏之一, 王进进, 丁宁. 罕见成人肋骨郎格汉斯细胞组织细胞增生症被误诊为乳腺癌术后骨转移一例[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 380-383.
[2]	李世杰, 申传安. 烧伤合并吸入性损伤患者呼吸机相关肺炎的研究现状[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(04): 351-355.
[3]	王岩, 钱宏阳, 朱寅杰, 董柏君, 潘家骅, 薛蔚. 机器人辅助单孔腹膜外根治性前列腺切除治疗高危前列腺癌的瘤控效果初探[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 435-440.
[4]	胡思平, 熊性宇, 徐航, 杨璐. 衰老相关分泌表型因子在前列腺癌发生发展中的作用机制[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 425-434.
[5]	李鑫钊, 张廷涛, 朱峰, 刘金山, 刘大闯. 血纤维蛋白原、D-二聚体及碱性磷酸酶诊断前列腺癌骨转移的价值分析[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 459-463.
[6]	郑俊, 吴杰英, 谭海波, 郑安全, 李腾成. EGFR-MEK-TZ三联合分子的构建及其对去势抵抗性前列腺癌细胞增殖与凋亡的影响[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 503-508.
[7]	赵静. 高频超声对腹股沟斜疝的诊断价值研究[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 575-578.
[8]	陈嘉艺, 陈佳, 张曦, 张琦. 伴有“反晕征”的IgG4 相关性肺疾病一例并文献复习[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 844-846.
[9]	杨柳, 陈佳, 孙雅娟, 陈娇, 谭明超, 龚明福. 抗中性粒细胞胞浆抗体相关性血管炎的胸部CT 及临床特征分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 744-749.
[10]	刘春军, 严方方, 王宝锋, 常婷婷, 郭红红, 李志强. 替加环素联合人免疫球蛋白治疗XDRAB致VAP 的疗效分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 797-800.
[11]	王涛, 刘静, 高玉伟, 王兴华, 胡秀红, 崔红蕊, 徐保振, 杨洪娟. 抗生素耐药背景下中医药防治腹膜透析相关性腹膜炎研究进展[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 340-344.
[12]	刘思含, 张静. 老年人血清铁与C 反应蛋白的比值及25-羟基维生素D3 与肾功能受损的关系研究[J/OL]. 中华肾病研究电子杂志, 2024, 13(05): 268-272.
[13]	杨森, 阙玉梅, 丁莉, 王艺瑾, 侯庆宇. Hcy和AD7c-NTP在阿尔茨海默病诊断中的临床应用[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(04): 208-212.
[14]	李璇, 邓岚, 郭微, 邓永梅, 刘杰昕. 标准化皮肤管理流程在防治脑卒中患者失禁相关性皮炎中的应用[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 479-482.
[15]	刘志超, 胡风云, 温春丽. 山西省脑卒中危险因素与地域的相关性分析[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 424-433.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Correlation and diagnostic value of plasma fibrinogen with bone metastasis in prostate cancer patients

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Correlation and diagnostic value of plasma fibrinogen with bone metastasis in prostate cancer patients